Budget Amount *help |
¥4,420,000 (Direct Cost: ¥3,400,000、Indirect Cost: ¥1,020,000)
Fiscal Year 2010: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
Fiscal Year 2009: ¥2,730,000 (Direct Cost: ¥2,100,000、Indirect Cost: ¥630,000)
|
Research Abstract |
Migration Stimulating Factor (MSF) enhanced cancer progression by stimulating of cancer migration and angiogenic. In vitro study, combination therapy of siRNA against MSF (MSF siRNA) and anti cancer drug demonstrated additive effect. In vivo study, treatment with MSF siRNA only or combination therapy of MSF siRNA and anti cancer drug showed anti cancer effect against nudemice bearing B88, oral SCC.
|